All lobbying filings

ZIMMER BIOMET, INC.

Lobbying for ZIMMER BIOMET, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $190,000.00 expenses · posted Jul 15, 2026

Official filing document

Bills named in this filing 2

HR 3006
To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an am…
S 1776
Medicare Beneficiary Co-Pay Fairness Act

Lobbying activity 7

Medicare/Medicaid

Artificial Intelligence and Machine Learning regulation and Medicare payment; Medicare Coverage of Innovative Medical Device; Medicare Physician Payment; Medicare Ambulatory Surgery Center and Hospital Outpatient Payment; Co-Pay Cap - H.R. 3006; S. 1776;

Trade (domestic/foreign)

Trade Issues/Policy

Taxation/Internal Revenue Code

Tax Issues; Medical Device Tax repeal

Chemicals/Chemical Industry

EPA Regulations of Ethylene Oxide Sterilization of Medical Devices; EPA Regulations of PFAS

Medical/Disease Research/Clinical Labs

Breakthrough devices;

Science/Technology

e-labeling; Breakthrough devices

Tariff (miscellaneous tariff bills)

Tariff policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.